TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2014

A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients.

Craig S Sauter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.